Pulse Biosciences, Inc - Common Stock — Filings & Documents (NASDAQ:PLSE) — Page 22 | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

2016

Quarterly report, Q2 FY2016

PULSE BIOSCIENCES, INC. quarterly report, Q2 FY2016

Quarterly report, Q1 FY2016

PULSE BIOSCIENCES, INC. quarterly report, Q1 FY2016

News

Oppenheimer Maintains Outperform on Pulse Biosciences, Raises Price Target to $60

Canaccord Genuity Maintains Buy on Pulse Biosciences, Raises Price Target to $58

Pulse Biosciences: Promising Technology, But Hard To Justify Its Valuation (NASDAQ:PLSE)

TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday

This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

BTIG Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $70

Top 3 Health Care Stocks That May Keep You Up At Night In Q3 - Veeva Systems (NYSE:VEEV), Pulse Bioscienc

Stocks Settle Lower on Rising Crude Prices and Higher Bond Yields

Stock Indices Waver on Strength in Chipmakers vs Weakness in Software Companies

This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - P

Pulse Biosciences, Inc. (PLSE) Q2 2026 Earnings Call Transcript

Pulse Biosciences, Inc (PLSE) Reports Q2 Loss, Misses Revenue Estimates